97 related articles for article (PubMed ID: 3045229)
1. Dapsone susceptibility of Mycobacterium leprae isolated before 1977.
Baohong J; de la Cruz EC; Levy L; Pattyn SR; Rees RJ
Int J Lepr Other Mycobact Dis; 1988 Jun; 56(2):326-8. PubMed ID: 3045229
[No Abstract] [Full Text] [Related]
2. Susceptibility of strains of Mycobacterium leprae isolated prior to 1977 from patients with previously untreated lepromatous leprosy.
Shepard CC; Rees RJ; Levy L; Pattyn SR; Baohong J; Dela Cruz EC
Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):11-5. PubMed ID: 3519796
[TBL] [Abstract][Full Text] [Related]
3. Dapsone susceptibility of M. leprae before and after 1977.
Almeida JG
Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):726-7. PubMed ID: 3323374
[No Abstract] [Full Text] [Related]
4. Drug susceptibility testing of Mycobacterium leprae.
Baohong J
Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4 Suppl):830-5. PubMed ID: 3325575
[No Abstract] [Full Text] [Related]
5. Grades of dapsone resistance to Mycobacterium leprae (burrowing terminology).
Roy RG
Lepr India; 1983 Jan; 55(1):179-80. PubMed ID: 6348411
[No Abstract] [Full Text] [Related]
6. The killing of Mycobacterium leprae in mice by various dietary concentrations of dapsone and rifampicin.
Gelber RH
Lepr Rev; 1986 Dec; 57(4):347-53. PubMed ID: 3540497
[No Abstract] [Full Text] [Related]
7. The sensitivity to Dapsone (DDS) of Mycobacterium leprae from patients with and without previous treatment.
Shepard CC; Levy L; Fasal P
Am J Trop Med Hyg; 1969 Mar; 18(2):258-63. PubMed ID: 4888029
[No Abstract] [Full Text] [Related]
8. Clarithromycin is bactericidal against strains of Mycobacterium leprae resistant and susceptible to dapsone and rifampin.
Walker LL; Van Landingham RM; Shinnick TM
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):59-65. PubMed ID: 8326182
[TBL] [Abstract][Full Text] [Related]
9. Dapsone-resistant Mycobacterium leprae in a patient receiving dapsone in low doses.
Browne SG
Int J Lepr Other Mycobact Dis; 1969; 37(3):296-301. PubMed ID: 4906048
[No Abstract] [Full Text] [Related]
10. Dapsone, folate synthesis and M. leprae.
Chatterjee BR
Indian J Lepr; 1990; 62(4):459-66. PubMed ID: 2086681
[No Abstract] [Full Text] [Related]
11. Drug susceptibility of Mycobacterium leprae: a retrospective analysis of mouse footpad inoculation results from 1983 to 1997.
Sekar B; Elangeswaran N; Jayarama E; Rajendran M; Kumar SS; Vijayaraghavan R; Anandan D; Arunagiri K
Lepr Rev; 2002 Sep; 73(3):239-44. PubMed ID: 12449888
[TBL] [Abstract][Full Text] [Related]
12. Letter: Sensitivity of Mycobacterium leprae to dapsone, studied in the rat.
Pattyn SR; Verdoolaeghe-Van Loo G
Int J Lepr Other Mycobact Dis; 1974; 42(1):72-3. PubMed ID: 4606751
[No Abstract] [Full Text] [Related]
13. Studies on sulphone resistant strains of M. leprae in field and institutionalized cases of leprosy.
Balakrishnan S; Seshadri PS; Neelan PN; Venkataramaniah HN; Harikrishnan S; Bhatia VN
Lepr India; 1983 Jan; 55(1):71-5. PubMed ID: 6348413
[TBL] [Abstract][Full Text] [Related]
14. Primary dapsone resistance in leprosy.
Vaishnavi C; Ganguly NK; Kumar B; Kaur S; Chakravarti RN
Indian J Lepr; 1985; 57(3):507-13. PubMed ID: 3913705
[TBL] [Abstract][Full Text] [Related]
15. Drug resistance of Mycobacterium leprae, particularly to DDS.
Rees RJ
Int J Lepr Other Mycobact Dis; 1967; 35(4):625-38. PubMed ID: 4173566
[No Abstract] [Full Text] [Related]
16. Combined clofazimine- and dapsone-resistant leprosy. A case report.
Kar HK; Bhatia VN; Harikrishnan S
Int J Lepr Other Mycobact Dis; 1986 Sep; 54(3):389-91. PubMed ID: 3528345
[TBL] [Abstract][Full Text] [Related]
17. Dapsone resistance in North India.
Sreevatsa ; Girdhar BK; Ramu G; Desikan KV
Indian J Lepr; 1985; 57(3):514-8. PubMed ID: 3913706
[TBL] [Abstract][Full Text] [Related]
18. Increase in prevalence of leprosy caused by dapsone-resistant Mycobacterium leprae.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1982 Jan; 30(52):637-8. PubMed ID: 6798411
[No Abstract] [Full Text] [Related]
19. Permeability of Mycobacterium leprae to dapsone: alteration by purification procedures.
Prabhakaran K; Harris EB; Kirchheimer WF
Lepr India; 1981 Apr; 53(2):160-2. PubMed ID: 6789004
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of secondary dapsone resistance in Nepal.
Samuel NM; Samuel S; Loudon J; Neupani K; Adiga RB
Indian J Lepr; 1984; 56(4):823-7. PubMed ID: 6398344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
